Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

SARS-CoV-2 in the Environment: Its Transmission, Mitigation, and

Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell

Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019

Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell

Frontiers Can Algal Derived Bioactive Metabolites Serve as

Nutraceuticals, Free Full-Text

Frontiers Carrageenan From Kappaphycus alvarezii (Rhodophyta

Antioxidants, Free Full-Text

Biosensors, Free Full-Text

Frontiers Low Acyl Gellan as an Excipient to Improve the

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in

Antiviral activity of lambda-carrageenan against influenza viruses

Iota-carrageenan extracted from red algae is a potent inhibitor of

Carrageenan nasal spray may double the rate of recovery from